Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain

Indinavir is a protease inhibitor used in the treatment of HIV infection. However, it has limited efficacy in eradicating the virus in the brain due to efflux by P-glycoprotein (P-gp) expressed at the blood-brain barrier (BBB). The objective of this work was to develop an o/w lipid nanoemulsion (LNE...

Full description

Saved in:
Bibliographic Details
Main Authors: Kandadi Prabhakar (Author), Syed Muzammil Afzal (Author), Goparaboina Surender (Author), Veerabrahma Kishan (Author)
Format: Book
Published: Elsevier, 2013-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ae3cf9df8b54d0c95ae733aff35f1d2
042 |a dc 
100 1 0 |a Kandadi Prabhakar  |e author 
700 1 0 |a Syed Muzammil Afzal  |e author 
700 1 0 |a Goparaboina Surender  |e author 
700 1 0 |a Veerabrahma Kishan  |e author 
245 0 0 |a Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain 
260 |b Elsevier,   |c 2013-09-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 2211-3843 
500 |a 10.1016/j.apsb.2013.08.001 
520 |a Indinavir is a protease inhibitor used in the treatment of HIV infection. However, it has limited efficacy in eradicating the virus in the brain due to efflux by P-glycoprotein (P-gp) expressed at the blood-brain barrier (BBB). The objective of this work was to develop an o/w lipid nanoemulsion (LNE) of indinavir using Tween 80 as co-emulsifier to improve its brain specific delivery. LNEs were prepared with different compositions and were characterized for globule size, polydispersity index, zeta potential and in vitro drug release. Five formulations were then evaluated for drug content, entrapment efficiency and stability after which brain uptake studies were carried out using fluorescent labeled LNEs and pharmacokinetic (PK) and tissue distribution studies were conducted after intravenous administration in mice. Brain uptake of indinavir was shown to be improved for a 1% Tween 80 containing formulation (F5) compared to a formulation containing 0.3% cholesterol (F2). In PK studies, the brain level of indinavir subsequent to administration of F5 was significantly (P<0.05) higher than produced by administration of a drug solution (2.44-fold) or a control nanoemulsion (F1) (1.48-fold) or formulation F2 (1.6-fold). The increased brain specific accumulation of indinavir from F5 is probably due to enhanced low density lipoprotein-mediated endocytosis and P-gp inhibition by Tween 80 at the BBB. These results suggest Tween 80 containing LNEs could provide a simple but effective means of delivering indinavir to brain. 
546 |a EN 
690 |a Tween 80 
690 |a Indinavir 
690 |a Lipid nanoemulsions 
690 |a Brain delivery 
690 |a Therapeutic availability 
690 |a Fluorescent DiD oil 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 3, Iss 5, Pp 345-353 (2013) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383513000774 
787 0 |n https://doaj.org/toc/2211-3835 
787 0 |n https://doaj.org/toc/2211-3843 
856 4 1 |u https://doaj.org/article/8ae3cf9df8b54d0c95ae733aff35f1d2  |z Connect to this object online.